Search hospitals > Illinois > Peoria
Saint Jude Midwest Affiliate
Claim this profilePeoria, Illinois 61602
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Lymphoma
Conducts research for Neuroblastoma
172 reported clinical trials
3 medical researchers
Summary
Saint Jude Midwest Affiliate is a medical facility located in Peoria, Illinois. This center is recognized for care of Cancer, Brain Tumor, Adult T-Cell Leukemia/Lymphoma, Lymphoma, Neuroblastoma and other specialties. Saint Jude Midwest Affiliate is involved with conducting 172 clinical trials across 310 conditions. There are 3 research doctors associated with this hospital, such as Jaime M. Libes, Amber M. D'Souza, and Prerna Kumar.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Top PIs
Jaime M. LibesSaint Jude Midwest Affiliate8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
56 reported clinical trials
99 drugs studied
Amber M. D'SouzaSaint Jude Midwest Affiliate8 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
37 reported clinical trials
83 drugs studied
Prerna KumarSaint Jude Midwest Affiliate3 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
37 reported clinical trials
89 drugs studied
Clinical Trials running at Saint Jude Midwest Affiliate
Testicular cancer
Wilms Tumor
Cancer
Testicular Carcinoma
Acute Lymphoblastic Leukemia
Germ Cell Tumors
Ovarian Carcinoma
Ovarian Tumors
Ovarian Choriocarcinoma
Brain Tumor
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Chemotherapy + Radiation Therapy
for Brain Cancer
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.
Recruiting1 award Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Jude Midwest Affiliate?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.